Bharat Dynamics to establish two new manufacturing facilities in Telangana and Uttar Pradesh Mar 25, 2026
Aurobindo Pharma’s subsidiary facility classified as ‘Voluntary Action Indicated’ by US FDA Mar 20, 2026
MedPlus Health Services faces potential revenue loss of Rs 4.79 lakh due to drug license suspensions Mar 14, 2026